These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9382742)

  • 1. Vaccination by aerosols: modulation of clearance mechanisms in the lung.
    Hensel A; Lubitz W
    Behring Inst Mitt; 1997 Feb; (98):212-9. PubMed ID: 9382742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML; Arêas AP; Ho PL
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of vaccines against bacterial diseases in swine: what can we expect?
    Haesebrouck F; Pasmans F; Chiers K; Maes D; Ducatelle R; Decostere A
    Vet Microbiol; 2004 Jun; 100(3-4):255-68. PubMed ID: 15145504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
    Cripps AW; Dunkley ML; Clancy RL; Kyd J
    Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunization against respiratory bacterial pathogens.
    Foxwell AR; Kyd JM; Cripps AW
    Expert Rev Vaccines; 2003 Aug; 2(4):551-60. PubMed ID: 14711339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.
    O'Hagan DT
    Clin Pharmacokinet; 1992 Jan; 22(1):1-10. PubMed ID: 1559304
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies.
    Uren TK; Wijburg OL; Simmons C; Johansen FE; Brandtzaeg P; Strugnell RA
    Eur J Immunol; 2005 Jan; 35(1):180-8. PubMed ID: 15593123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial-gut interactions in health and disease. Mucosal immune responses.
    Acheson DW; Luccioli S
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):387-404. PubMed ID: 15123077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live bacterial delivery systems for development of mucosal vaccines.
    Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M
    Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
    Spreng S; Viret JF
    Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen sampling by epithelial tissues: implication for vaccine design.
    Kraehenbuhl JP; Hopkins SA; Kernéis S; Pringault E
    Behring Inst Mitt; 1997 Feb; (98):24-32. PubMed ID: 9382745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of mucosal vaccines to Peyer's patch M cells.
    Frey A; Neutra MR
    Behring Inst Mitt; 1997 Feb; (98):376-89. PubMed ID: 9382762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.
    Dougan G; Ghaem-Maghami M; Pickard D; Frankel G; Douce G; Clare S; Dunstan S; Simmons C
    Philos Trans R Soc Lond B Biol Sci; 2000 May; 355(1397):705-12. PubMed ID: 10874742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.
    Buddenborg C; Daudel D; Liebrecht S; Greune L; Humberg V; Schmidt MA
    Int J Med Microbiol; 2008 Jan; 298(1-2):105-14. PubMed ID: 17936683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vivo analysis of IgA- and IgG-mediated mucosal defense against bacterial pathogens.
    Steinmetz I
    Behring Inst Mitt; 1997 Feb; (98):53-5. PubMed ID: 9382769
    [No Abstract]   [Full Text] [Related]  

  • 20. Mucosal vaccination against bacterial respiratory infections.
    Baumann U
    Expert Rev Vaccines; 2008 Oct; 7(8):1257-76. PubMed ID: 18844598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.